Neuralstem to Participate at the Young Jewish Professionals CEO Healthcare Symposium

GERMANTOWN, Md., Feb. 8 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Richard Daly, Chairman and CEO of Neuralstem, will participate in a panel discussion entitled, “From Research & Development to Commercial Venture: Building a Successful Biotech Company” at the Young Jewish Professionals CEO [...]